Zen Health Logo
ABOUT ZEN HEALTH

Built by clinical safety experts, biostatisticians, and compliance engineers.

Zen Health was founded to solve two of clinical development’s most critical operational vulnerabilities: unverified pharmacovigilance case review and uncalibrated trial protocol feasibility.

In safety, sponsors delegate case processing to CROs but bear 100% regulatory liability when inspections occur. In clinical trials, fragmented protocol authoring and guesswork around enrollment timelines trigger multi-million dollar amendments and delayed market entries.

We built Zen Case AI and Zen Protocol AI to change that. Physician-centered, mathematically grounded, and strictly non-authoritative. Engineered for the medical review team that demands defensible case quality—and the clinical researchers launching tomorrow's breakthrough trials.

OUR LEADERSHIP & TEAM

Meet the Team Building Zen Health

A multidisciplinary team of engineering, clinical R&D, product design, and executive leaders committed to advancing patient safety and clinical trial execution.

Soumyadip Ghosal
FOUNDER & CEO

Soumyadip Ghosal

Building Zen Health, transforming pharmacovigilance medical review (Zen Case AI) and ICH M11 clinical trial protocol intelligence (Zen Protocol AI).

LinkedIn
Archanaditya Sarkar

Archanaditya Sarkar

CHIEF OPERATING OFFICER
Zen HealthLinkedIn
Sayan Dey

Sayan Dey

CHIEF TECHNOLOGY OFFICER
Zen HealthLinkedIn
Rajdeep Ghosh

Rajdeep Ghosh

HEAD OF ENGINEERING
Zen HealthLinkedIn
Amit Gorai

Amit Gorai

PRODUCT DESIGNER
Zen HealthLinkedIn

Board of Advisory

Delivered by the named principals

Dr. Praveen Vadlamudi

Dr. Praveen Vadlamudi

Physician-Entrepreneur | CEO @ Aetos Healthcare | Scaling RPM, CCM, BHI & AI-Driven Virtual Care

Sherifuddin Sheriff Shaik

Sherifuddin Sheriff Shaik

Physician | Clinical Research Expert | Medical Advisor to US & EU Pharma | BE Studies & Global CRO Oversight

Elias Tharakan

Elias Tharakan

Architect of the industry's first unified EDC + RTSM + eCOA + Safety suite, powering 1,000+ trials across 90+ countries.

Dr. Ashok Srivastava

Dr. Ashok Srivastava

MD, Ph.D., MBA

Board-certified oncologist. 135 trials, 11 first-in-human, 27 INDs, 9 NDAs, 3 BLAs including AUCATZYL® (obe-cel) CD19 CAR-T.

GOVERNANCE PRINCIPLES

Built for Clinical Safety, Trial Integrity & Audit Readiness

Omnichannel Ingestion & Standard Normalization

Connects directly to EMR/EHR, EDC, and safety databases (Argus, ArisG, Veeva). Incoming clinical data is normalized to FHIR R4 and ICH E2B(R3) schemas with quarantine logging for invalid payloads.

Deterministic Calculations & Monte Carlo Simulation

Eligibility rules (Criteria DSL) and feasibility simulations (Poisson-Gamma accrual) are computed strictly with deterministic statistical code, avoiding generative AI math hallucinations.

Credentialed Physician & PI Adjudication

Named board-certified physicians and Principal Investigators confirm, edit, or override AI recommendations with mandatory rationale capture. AI is strictly non-authoritative.

21 CFR Part 11 & Append-Only Audit Trails

Database-level triggers enforce write-only ledgers for audit records, reviews, and dual electronic signatures with OTP re-authentication. Produces inspection-ready exports for global health authorities.

Get in touch.

For partnership inquiries, pilot scoping, or press.